Masimo | MASI - Cost Of Sales


Masimo reported $152.8M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 303.5M 60.47M Mar/2026
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Dexcom USD 441.6M 25.3M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
General Electric Aerospace USD 8.15B 764M Mar/2026
Globus Medical USD 263.59M 26.88M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Masimo USD 152.8M 12.4M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Orthofix International USD 66.63M 6.4M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
ResMed USD 551.67M 4.17M Mar/2026
Steris USD 891.3M 50.6M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026